The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
 
 

Rationale for prescription omega-3-acid ethyl ester therapy for hypertriglyceridemia: a primer for clinicians.

Very high triglyceride (TG) levels may cause pancreatitis. Elevated TG levels are also often, but not always, a risk factor for atherosclerotic coronary heart disease. Omega-3 fatty acids are polyunsaturated fatty acids found in the oil of fish and other seafood that, when consumed, lower TG levels and reduce the risk of cardiovascular events. Prescription omega-3-acid (P-OM3) ethyl ester is a fish oil formulation that has undergone the rigorous regulatory steps required to obtain US Food and Drug Administration approval as a prescription drug. P-OM3 is derived from marine fish, which are high in omega-3 fatty acids. While omega-3 fatty acids may sometimes increase low- density lipoprotein cholesterol (LDL-C) levels in hypertriglyceridemic patients, non-high-density lipoprotein cholesterol (non-HDL-C) levels are often decreased. This has clinical significance because: 1) non-HDL-C sums the cholesterol carried by atherogenic lipoproteins beyond that of LDL-C alone; 2) non-HDL-C is a better predictor of atherogenic risk compared to LDL-C alone; and 3) after LDL-C treatment goals have been reached, non-HDL-C is a recommended secondary lipid treatment target in patients with persistent TG > or = 200 mg/dl. This paper reviews the U.S. treatment indications for P-OM3, clinical evaluation of hypertriglyceridemic patients, importance of elevated TG levels, relevant TG biochemistry and metabolism, illustrative genetic dyslipidemias, lipid treatment recommendations, fat and fatty acid biochemistry, omega-3 fatty acid biochemistry, and the basis behind recommending omega-3 fatty acids to reduce cardiovascular risk. Finally, this review examines P-OM3's lipid and cardiovascular effects, safety, and tolerability, as well as its practical role in patient management.[1]

References

 
WikiGenes - Universities